Crossing the barrier: treatment of brain tumors using nanochain particles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Crossing the barrier: treatment of brain tumors using nanochain particles

Published:2016-01-09 Issue:5 Volume:8 Page:678-695
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Karathanasis Efstathios¹,Ghaghada Ketan B.²

Affiliation:

1. Department of Biomedical Engineering and Department of Radiology, Case Comprehensive Cancer CenterCase Western Reserve UniversityClevelandOHUSA

2. Edward B. Singleton Department of Pediatric Radiology, Texas Children's Hospital, Department of RadiologyBaylor College of MedicineHoustonTXUSA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1387

Reference144 articles.

1. Gliomas—past, present, and future;Black KL;Clin Neurosurg,1999

2. Current status of local therapy in malignant gliomas — A clinical review of three selected approaches

3. Glioblastoma multiforme: a review of where we have been and where we are going

4. High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

5. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal Nanomaterials: A Rising Star in Glioma Treatment;International Journal of Nanomedicine;2024-07

2. Nanotechnology-based delivery systems to overcome drug resistance in cancer;Medical Review;2024-02-01

3. Advances in Gold Nanoparticles: Synthesis, Functionalization Strategies, and Theranostic Applications in Cancer;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

4. Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression;BMC Cancer;2023-11-17

5. Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery;Acta Biomaterialia;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3